Latha Radhakrishnan
Clinical Assistant Professor, Pharmacy Practice
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
PDAT 9: Hematology/Oncology (PHAR 509), 1/9/2023 – 4/28/2023
Malta University, 4/6/2022 – 5/10/2022
PHAR 509 Hematology Oncology (509), 1/17/2022 – 5/9/2022
Introductory to Pharmacy Practice (PHAR 411), 8/23/2021 – 12/8/2021
PHAR 509 Hematology Oncology (509), 1/18/2021 – 5/10/2021
Undergrad Resrch Pharm Pract (PMPR 380), 1/11/2021 – 4/30/2021
Introduction Pharmacy Practice (411), 8/24/2020 – 12/6/2021
International Clinical Education, 7/6/2020 – Present
Selected Publications
Radhakrishnan, Latha, Wirth, Scott. (2019). Oncology-Related Medications. Synopsis of Neurology, Psychiatry and Related Systemic Disorders. Cambridge University Press.
Ellinger, Lara, Radhakrishnan, Latha, Cuellar, Sandra. (2016). Pharmacists Perspective on Management of GBM. Cancer therapy & Oncology International Journal, 2, (2). doi:10.19080/ctoij.2016.02.555583.
Natarajan, Nirmala, Panneerselvam, Lakshmipriya, Radhakrishnan, Latha. (2015). Heart rate variability among reproductive and postmenopausal women. International Journal of Medical Science and Public Health, 4, (8), 1132. doi:10.5455/ijmsph.2015.13022015252.
Popa, AM, Valla, K, Radhakrishnan, L, Cuellar, S, Lee Villano, J. (2012). Bevacizumab-induced oral mucositis in background of cutaneous plaque-type psoriasis. Annals of Pharmacotherapy, 46, (11). doi:10.1345/aph.1R350.
Radhakrishnan, L. (2009). A review of testicular cancer. U.S. Pharmacist, 34, (8).
Shord, SS, Bressler, LR, Radhakrishnan, L, Chen, N, Villano, JL. (2009). Evaluation of the modified diet in renal disease equation for calculation of carboplatin dose. Annals of Pharmacotherapy, 43, (2), 235-241. doi:10.1345/aph.1L446.
Villano, JL, Bressler, L, Radhakrishnan, L, Cuellar, S, Shord, SS. (2007). Comparing carboplatin dose administered to the calculated dose using the Modification of Diet and Renal Disease (MDRD) equation. Journal of Clinical Oncology, 25, (18_suppl), 13003-13003. doi:10.1200/jco.2007.25.18_suppl.13003.
Villano, JL, Mehta, D, Radhakrishnan, L. (2006). Abraxane® induced life-threatening toxicities with metastatic breast cancer and hepatic insufficiency. Investigational New Drugs, 24, (5), 455-456. doi:10.1007/s10637-006-6214-0.
Professional Leadership
HOPA Leadership Committee, 6/1/2021 - 6/1/2022
Annual Conference Session Proposal Subcommittee, 4/22/2020 - Present
Intravenous Chemotherapy Education Committee, 5/1/2019 - Present
President, 8/8/2018 - Present
Treatment Support Kit Committee, 3/22/2018 - Present
Chapter Enhancement Task Force, 8/7/2017 - 8/29/2019
Advisory Committee, 8/3/2017 - Present
Past President, 7/19/2017 - Present
Inernational President, 8/8/2015 - 8/5/2017
Notable Honors
2021, 2021 NCODA Living the Mission Award Nominee, National Community Oncology Drug Association
2020, 2020 NCODA Living the Mission Award Nominee, NCODA
2019, 2019 NCODA Living the Mission Award Nominee,
Selected Presentations
Radhakrishnan, Latha, Leonard, Alyson, Leal, Ticiana. (2022 April 29). A Different EGFR Mutation (EGFR Exon 20) Requires New Treatment Approaches in NSCLC Continuing Education Presentation. National Community Oncology Dispensing Association Spring Forum. Atlanta, GA.
Radhakrishnan, Latha, Forsberg, Paul. (2022 March 30). Optimizing Frontline Immunotherapy Outcomes in NSCLC and Managed Care Considerations. Academy of Managed Care Pharmacy Annual Meeting. Chicago, IL.